Cellbion Co Ltd (308430) Stock Price & News

308430:KOSDAQ

Cellbion Co Ltd

₩17,610.00

-1.78%

(-320.00) 1D

Jun 10, 3:15:18 PM GMT+9 · KRW

All symbols

YTD

MAX

	Symbol	Price	Change	% Change

Generating top insights for 308430...

Open

₩17,990

High

₩19,000

Low

₩17,290

Mkt. cap

227.26B

Avg. vol.

105.17K

Volume

26.98K

52-wk high

₩42,200

52-wk low

₩15,700

EPS

-₩713

Shares outstanding

12.91M

No. of employees

Open

₩17,990

High

₩19,000

Low

₩17,290

Mkt. cap

227.26B

Avg. vol.

105.17K

Volume

26.98K

52-wk high

₩42,200

52-wk low

₩15,700

EPS

-₩713

Shares outstanding

12.91M

No. of employees

Related stocks

Curiox BioSystems Co Ltd

₩69,000.00

-7.51%

254490

Mirai Semiconductors Co Ltd

₩23,300.00

-4.12%

News stories

From sources across the web

Morningstar

7 minutes ago

Acer Listed on 2026 Dow Jones Best-in-Class World Index

Automotive World

2 hours ago

Einride goes public on Nasdaq with US$1.35bn valuation

TradingView

1 hour ago

Nordtech Announces IPO Outcome, Listing On Nasdaq Stockholm

Fortune

8 hours ago

Wall Street dumped nearly $1 trillion in tech stocks by midday—then clawed it back and bought peanut butter and paint

About Cellbion Co Ltd

CEO-

Employees60

Founded2010

Headquarters-

SectorPharmaceutical industry

Websitecellbion.co.kr

All values in KRW	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue	404.46M	530.52M	530.52M	612.53M
Cost of goods sold	349.87M	585.18M	585.18M	615.93M
Cost of revenue	349.87M	585.18M	585.18M	615.93M
Research and development expenses	1.34B	1.29B	1.29B	1.39B
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	794.09M	837.81M	837.81M	755.48M
Operating expense	2.14B	2.20B	2.20B	2.44B
Total operating expenses	2.49B	2.78B	2.78B	3.06B
Operating income	-2.08B	-2.25B	-2.25B	-2.44B
Other non operating income	14.26K	-3.47M	-3.47M	1.12K
EBT including unusual items	-1.89B	-2.13B	-2.13B	-2.40B
EBT excluding unusual items	-1.89B	-2.13B	-2.13B	-2.40B
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	68.16M	68.16M	44.32M
Net income	-1.89B	-2.13B	-2.13B	-2.40B
Net profit margin	-468.05%	-400.88%	-400.88%	-391.47%
Earnings per share	-	-	-	-
Interest and investment income	214.37M	177.30M	177.30M	135.49M
Interest expense	-23.34M	-46.08M	-46.08M	-94.85M
Net interest expenses	191.03M	131.22M	131.22M	40.64M
Depreciation and amortization charges	-	-	-	224.44M
EBITDA	-2.03B	-2.18B	-2.18B	-2.14B
Gain or loss from assets sale	500.00	12.54K	12.54K	-5.21M

AI content may include mistakes. Learn more

HelpSend feedbackPrivacy Terms Disclaimer

Finance

Research